Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Maresca KP"'
Autor:
Barrett JA, Joyal JL, Hillier SM, Maresca KP, Femia FJ, Kronauge JF, Boyd M, Mairs RJ, Babich JW
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Jun2010, Vol. 25 Issue 3, p299-308, 10p
Autor:
Wakabayashi Y; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Stenkrona P; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Arakawa R; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Yan X; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Van Buskirk MG; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Jenkins MD; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Santamaria JAM; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Maresca KP; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Takano A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Liow JS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Chappie TA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Varrone A; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Nag S; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Zhang L; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Hughes ZA; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Schmidt CJ; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Doran SD; Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and., Mannes A; Anesthesia Department, NIH Clinical Center, Bethesda, Maryland., Zanotti-Fregonara P; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Ooms M; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Morse CL; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Zoghbi SS; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Halldin C; Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden., Pike VW; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland., Innis RB; Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland; robert.innis@nih.gov.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Dec; Vol. 63 (12), pp. 1919-1924. Date of Electronic Publication: 2022 Jun 30.
Autor:
Arakawa R; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden. ryosuke.arakawa@ki.se.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden. ryosuke.arakawa@ki.se., Takano A; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Nag S; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Jia Z; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Amini N; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Maresca KP; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Zhang L; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Keliher EJ; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Butler CR; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Piro JR; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Samad TA; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Smith D; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Nason D; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., O'Neil S; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Trapa P; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Fonseca KR; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Litchfield J; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., McCarthy T; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Carson RE; Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA., Halldin C; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Publikováno v:
EJNMMI research [EJNMMI Res] 2022 Mar 04; Vol. 12 (1), pp. 13. Date of Electronic Publication: 2022 Mar 04.
Autor:
Maresca KP; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA. kevin.maresca@pfizer.com., Chen J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Mathur D; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Regneron Pharmaceuticals, Tarrytown, NY, USA., Giddabasappa A; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Root A; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Generate Biomedicines, Inc, Cambridge, MA, USA., Narula J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., King L; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Schaer D; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Golas J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Regneron Pharmaceuticals, Tarrytown, NY, USA., Kobylarz K; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Rosfjord E; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Black Diamond Therapeutics, New York, NY, USA., Keliher E; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Chen L; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Ram S; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Pickering EH; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Hardwick JS; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Rejto PA; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Hussein A; Invicro, A Konica Minolta Company, New Haven, USA., Ilovich O; Invicro, A Konica Minolta Company, New Haven, USA., Staton K; Evergreen Theragnostics, Jersey City, NJ, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wilson I; ImaginAb Inc., Inglewood, CA, USA., McCarthy TJ; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.
Publikováno v:
Molecular imaging and biology [Mol Imaging Biol] 2021 Dec; Vol. 23 (6), pp. 941-951. Date of Electronic Publication: 2021 Jun 18.
Autor:
Zhang L, Butler CR, Maresca KP, Takano A; Department of Clinical Neuroscience, Center for Psychiatry Research , Karolinska Institutet and Stockholm County Council , SE-17176 Stockholm , Sweden., Nag S; Department of Clinical Neuroscience, Center for Psychiatry Research , Karolinska Institutet and Stockholm County Council , SE-17176 Stockholm , Sweden., Jia Z; Department of Clinical Neuroscience, Center for Psychiatry Research , Karolinska Institutet and Stockholm County Council , SE-17176 Stockholm , Sweden., Arakawa R; Department of Clinical Neuroscience, Center for Psychiatry Research , Karolinska Institutet and Stockholm County Council , SE-17176 Stockholm , Sweden., Piro JR, Samad T, Smith DL, Nason DM, O'Neil S, McAllister L, Schildknegt K, Trapa P, McCarthy TJ, Villalobos A, Halldin C; Department of Clinical Neuroscience, Center for Psychiatry Research , Karolinska Institutet and Stockholm County Council , SE-17176 Stockholm , Sweden.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2019 Sep 26; Vol. 62 (18), pp. 8532-8543. Date of Electronic Publication: 2019 Sep 16.
Autor:
Roth Flach RJ; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America., Su C; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America., Bollinger E; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America., Cortes C; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America., Robertson AW; Drug Safety Research and Development Global Pathology, Pfizer Inc., Groton, Connecticut, United States of America., Opsahl AC; Drug Safety Research and Development Global Pathology, Pfizer Inc., Groton, Connecticut, United States of America., Coskran TM; Drug Safety Research and Development Global Pathology, Pfizer Inc., Groton, Connecticut, United States of America., Maresca KP; Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts, United States of America., Keliher EJ; Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts, United States of America., Yates PD; Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts, United States of America., Kim AM; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America., Kalgutkar AS; Medicine Design, Pfizer Inc., Cambridge, Massachusetts, United States of America., Buckbinder L; Internal Medicine Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2019 Mar 19; Vol. 14 (3), pp. e0214150. Date of Electronic Publication: 2019 Mar 19 (Print Publication: 2019).
Autor:
Collier TL; 1 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital (MGH) & Department of Radiology, Harvard Medical School, Boston, MA, USA.; 2 Advion, Inc, Ithaca, NY, USA., Maresca KP; 3 Clinical and Translational Imaging, Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA., Normandin MD; 1 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital (MGH) & Department of Radiology, Harvard Medical School, Boston, MA, USA., Richardson P; 4 Medicinal Sciences, Pfizer Inc, La Jolla, CA, USA., McCarthy TJ; 3 Clinical and Translational Imaging, Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA., Liang SH; 1 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital (MGH) & Department of Radiology, Harvard Medical School, Boston, MA, USA., Waterhouse RN; 3 Clinical and Translational Imaging, Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA.; 5 Waterhouse Imaging and Biomarker Consultants, Chester, NH, USA., Vasdev N; 1 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital (MGH) & Department of Radiology, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Molecular imaging [Mol Imaging] 2017 Jan-Dec; Vol. 16, pp. 1536012117736669.
Autor:
Vallabhajosula S; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York svallabh@med.cornell.edu., Nikolopoulou A; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York., Babich JW; Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts; and., Osborne JR; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York., Tagawa ST; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York., Lipai I; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York., Solnes L; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York., Maresca KP; Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts; and., Armor T; Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts; and., Joyal JL; Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts; and., Crummet R; Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts; and., Stubbs JB; Radiation Dosimetry Systems, Inc, Alpharetta, Georgia., Goldsmith SJ; New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Nov; Vol. 55 (11), pp. 1791-8. Date of Electronic Publication: 2014 Oct 23.
Autor:
Chin BB; Department of Radiology, Duke University Medical Center, Durham, North Carolina., Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 May; Vol. 55 (5), pp. 765-71. Date of Electronic Publication: 2014 Mar 13.
Autor:
Hillier SM; Molecular Insight Pharmaceuticals, Cambridge, Massachusetts 02142, USA., Maresca KP, Lu G, Merkin RD, Marquis JC, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 Aug; Vol. 54 (8), pp. 1369-76. Date of Electronic Publication: 2013 Jun 03.